人参无公害农田栽培技术体系及发展策略Research on technology regulation of non-polluted cultivation and strategies of Panax ginseng cultivation in farmland
沈亮;李西文;徐江;董林林;张乃嘦;藤原直树;陈士林;
SHEN Liang;LI Xi-wen;XU Jiang;DONG Lin-lin;ZHANG Nai-wu;NAOLI Fujihara;CHEN Shi-lin;Institute of Chinese Materia Medica,China Academy of Chinese Medicinal Sciences;China Medico Corporation;Tsumura & Co.;
摘要(Abstract):
随着国家对伐林栽参可用林地的逐步限制,农田栽参将成为人参种植产业发展的主要模式,而无公害生产是未来人参产业发展的重要方向。通过多年农田栽参研究数据及产区调研结果,该文制订了人参无公害农田栽培技术体系。该体系包括人参生态适宜性数值区划确定农田栽参栽培用地、无公害种植方法、田间管理、病虫害防治、采收加工及质量控制等内容。该文提出农田栽参土壤修复,建立病虫害综合防治平台,培育适宜农田栽培的抗逆新品种,建立人参无公害种植产地溯源系统等技术策略,以促进农田栽参种植产业的健康可持续发展。
As the limit of the usage of available forest land,cultivated ginseng in the farmland would become the mainly Panax ginseng planting mode,meanwhile the non-polluted production technology would be the mainly development direction in the future. In this study,the non-polluted cultivation technology system of P. ginseng was established based on the research results of field investigation in the cultivated regions. The system includes suitable planting regions selecting,planting method,field management,pest control,harvesting & processing,and quality control. Aimed at the serious issues in the cultivation,research strategies have been provided to guarantee the sustainable development of the ginseng industry. The patterns of soil restoration after P. ginseng cultivation,establishment the platform of comprehensive disease & pest control,breeding new varieties for high stress tolerance and resistance,and a traceability system for P. ginseng cultivation. In all,these strategies was considered to largely developing of the ginseng industry in the green and sustainable way.
关键词(KeyWords):
人参;无公害种植;生态适宜性;土壤修复;产地溯源
Panax ginseng;non-polluted cultivation;ecological suitability;soil remediation;origin traceability
基金项目(Foundation): 国家中药标准化项目(ZYBZH-Y-TJ-43);; 中国博士后科学基金项目(2017M611128)
作者(Author):
沈亮;李西文;徐江;董林林;张乃嘦;藤原直树;陈士林;
SHEN Liang;LI Xi-wen;XU Jiang;DONG Lin-lin;ZHANG Nai-wu;NAOLI Fujihara;CHEN Shi-lin;Institute of Chinese Materia Medica,China Academy of Chinese Medicinal Sciences;China Medico Corporation;Tsumura & Co.;
Email:
DOI: 10.19540/j.cnki.cjcmm.2017.0130
参考文献(References):
- [1]吴征镒.人参属植物的三帖成分和分类系统、地理分布的关系[J].植物分类学报,1975,13(2):29.
- [2]中国药典.一部[S].2015:8.
- [3]路放,杨世海,孟宪兰.人参药理作用研究新进展[J].人参研究,2013(1):46.
- [4]沈亮,徐江,董林林,等.人参栽培种植体系及研究策略[J].中国中药杂志,2015,40(17):3367.
- [5]任跃英,张益胜,李国君,等.非林地人参种植基地建设的优势分析[J].人参研究,2011,2(2):34.
- [6]崔东河,田永全,郑殿家,等.农田地人参栽培技术要点[J].人参研究,2010,22(4):28.
- [7]牛玮浩,徐江,董林林,等.农田栽参的研究进展及优势分析[J],世界科学技术---中医药现代化,2016,18(11):1981.
- [8]陈士林,黄林芳,陈君,等.无公害中药材生产关键技术研究[J].世界科学技术---中医药现代化,2011,13(3):436.
- [9]杨崇仁.中药农药现状与对策[J].中国现代中药,2013,15(8):633.
- [10]魏赫,王莹,金红宇,等.植物生长调节剂研究进展及其在中药种植中使用和检测[J].中国药学杂志,2016,51(2):81.
- [11]王育民,殷秀岩,于鹏,等.西洋参生产技术标准操作规程(SOP)[J].现代中药研究与实践,2004,18(2):8.
- [12]杨俊,杨树中.无公害名特中药材金银花规范化栽培技术[J].陕西农业科学,2007(3):183.
- [13]李春雷.吉林省无公害山药栽培关键技术的研究[D].长春:吉林农业大学,2013.
- [14]董林林,谷丽婷,徐江,等.三七无公害栽培体系的探讨[J].世界科学技术---中医药现代化,2016,18(11):1975.
- [15]中国中药协会团体标准,T/CATCM 003-2017无公害三七药材及饮片农药与重金属及有害元素的最大残留限量[S].北京:中国标准出版社,2017.
- [16]张飞飞,任跃英,王天媛,等.无公害人参生产关键技术[J].现代农业科技,2017(1):70.
- [17]沈亮,吴杰,李西文,等.人参全球产地生态适宜性分析及农田栽培选地规范[J].中国中药杂志,2016,41(18):3314.
- [18]董林林,徐江,牛玮浩,等.改良措施对农田土壤微生态及人参存苗率的影响[J].中国中药杂志,2016,41(23):4334.
- [19]徐江,董林林,王瑞,等.综合改良对农田栽参土壤微生态环境的改善研究[J].中国中药杂志,2017,42(5):875.
- [20]陈士林.中国药材产地生态适应性区划[M].2版.北京:科学出版社,2017.
- [21]许世泉,张浩,徐怀友,等.白浆土栽培“福星1号”人参技术要点[J].特种经济动植物,2015(6):36.
- [22]中华人民共和国农业行业标准,NY/T 5295-2015无公害农产品产地环境评价准则[S].北京:中国标准出版社,2015.
- [23]孙小镭,姜慧玲,冯连杰,等.棉隆土壤熏蒸消毒技术规程[J].黄河蔬菜,2010(2):42.
- [24]翟建华,曹晓妹,王蓓,等.蔬菜大棚常用土壤消毒剂[J].北方园艺,2009(1):126.
- [25]中国人民共和国化工行业标准,HG2427-93氰氨化钙[S].北京:中国标准出版社,1993.
- [26]刘亚南,赵东岳,刘敏,等.人参病虫害发生及农药施用现状调查[J].中国农学通报,2014,30(10):294.
- [27]陈君,徐常青,乔海莉,等.我国中药材生产中农药使用现状与建议[J].中国现代中药,2016,18(3):263.
- [28]赵保文,张玉姣,张阳,等.延边州农田栽参现状与发展对策[J].中国林副特产,2016(2):104.
- [29]孙海,王秋霞,张迪迪,等.不同生长模式下人参土壤微生物群落结构研究[J].东北农业大学学报,2016,47(2):16.
- [30]曹坳程.溴甲烷及其替代产品[J].农药,2003,42(6):1.
- [31]贲海燕,崔国庆,石延霞,等.氰氨化钙土壤改良作用及其防治蔬菜土传病害效果[J].生态学杂志,2013,32(12):3318.
- [32]金永善,许永华,庞立杰,等.农田种植绿色人参技术研究[J].人参研究,2006(3):10.
- [33]张鹏,李西文,董林林,等.植物源农药研发及中药材生产中的应用现状[J].中国中药杂志,2016,41(19):3579.
- [34]南烟.吉林育出非林地种植人参新品种[J].北京农业,2012(12):54.
- [35]黎裕,王建康,邱丽娟.中国作物分子育种现状与发展前景[J].作物学报,2010(36):1425.
- [36]Sun C,Li Y,Wu Q,et al.De novo sequencing and analysis of the American ginseng root transcriptome using a GSFLXTitanium platform to discover putative genes involved in ginsenoside biosynthesis[J].BMC Genomics,2010,11(1):262.
- [37]Chen S L,Luo H,Li Y,et al.454 EST analysis detects gene sputatively involved in ginsenoside biosynthesis in Panax ginseng[J].Plant Cell Rep,2011,30(9):1593.
- [38]宋君,王东,郭灵安,等.利用DNA条码对农产品产地溯源研究---黑木耳产地分子溯源[J].分析试验室,2014,33(3):292.
- [39]Heaton K,Kelly S D,Hoogewerff J,et al.Verifying the geographical origin of beef:the application of multi-element isotope and trace element analysis[J].Food Chem,2008,107(1):506.
- [40]郭波莉,魏益民,Simon K D,等.稳定性氢同位素分析在牛肉产地溯源中的应用[J].分析化学,2009,37(9):1333.
- [41]廖保生,宋经元,谢彩香,等.道地药材产地溯源研究[J].中国中药杂志,2014,39(20):3881.
- [42]蔡勇,李西文,倪静云,等.基于二维码的中药质量可追溯系统[J].中药材,2016,39(2):275.
- [43]Cai Y,Li X W,Li M,et al.Traceability and quality control in traditional Chinese medicine:from chemical fingerprint to two-dimensions[J].Evid-Based Compl Alt,2015,doi.org/10.1155/2014/251304.
- [44]Cai Y,Hu H,Li X W,et al.Quality traceability system of traditional Chinese medicine based on two dimensional barcode using mobile intelligent technology[J].PLo S ONE,2016,11(10):e0165263.
- [45]Cai Y,Li P,Li X W,et al.Converting Panax ginseng DNA and chemical fingerprints into two-dimensional barcode[J].J Ginseng Res,2017,41(3):339.
- 人参
- 无公害种植
- 生态适宜性
- 土壤修复
- 产地溯源
Panax ginseng - non-polluted cultivation
- ecological suitability
- soil remediation
- origin traceability
- 沈亮
- 李西文
- 徐江
- 董林林
- 张乃嘦
- 藤原直树
- 陈士林
SHEN Liang- LI Xi-wen
- XU Jiang
- DONG Lin-lin
- ZHANG Nai-wu
- NAOLI Fujihara
- CHEN Shi-lin
- Institute of Chinese Materia Medica
- China Academy of Chinese Medicinal Sciences
- China Medico Corporation
- Tsumura & Co.
- 沈亮
- 李西文
- 徐江
- 董林林
- 张乃嘦
- 藤原直树
- 陈士林
SHEN Liang- LI Xi-wen
- XU Jiang
- DONG Lin-lin
- ZHANG Nai-wu
- NAOLI Fujihara
- CHEN Shi-lin
- Institute of Chinese Materia Medica
- China Academy of Chinese Medicinal Sciences
- China Medico Corporation
- Tsumura & Co.